ZFP36 and breast cancer: Since miR-29a is over-expressed in mesenchymal metastatic RasXT cells compared to epithelial EpRas cells, and also in breast cancer tissues 21, we questioned whether inhibition of miR29a could correct the TTP–HuR imbalance.